T-cell/histiocyte-rich large B-cell lymphoma displays a heterogeneity similar to diffuse large B-cell lymphoma: A clinicopathologic, immunohistochemical, and molecular study of 30 cases

Applied Immunohistochemistry and Molecular Morphology

Volumn 13, Issue 2, 2005, Pages 109-115

  Wang, Jun ^a   Sun, Nora C J ^c   Chen, Yuan Yuan ^b   Weiss, Lawrence M ^b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bcl 6; CD10; Heterogeneity; Immunohistochemistry; T cell histiocyte rich large B cell lymphoma

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; PARAFFIN; PROTEIN BCL 2; PROTEIN BCL 6; SYNDECAN 1;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER CELL; CANCER CLASSIFICATION; FEMALE; GENE REARRANGEMENT; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; T CELL HISTIOCYTE RICH LARGE B CELL LYMPHOMA; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GENES, IMMUNOGLOBULIN; HISTIOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES; TRANSLOCATION, GENETIC;

EID: 19444381659     PISSN: 15412016     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pai.0000132199.47017.35     Document Type: Article

References (23)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
2. Gatter KC, Warnke R. Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, Eds. World Health Organization Classification of Tumors: Pathology and Tumors of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001:171-174.
3. Achten R, Verhoef G, Vanuytsel L, et al. T-cell/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity. J Clin Oncol. 2002;20: 1269-1277.
4. Lim MS, Beaty M, Sorbara L, et al. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells. Am J Surg Pathol. 2002;26:1458-1466.
5. Fraga M, Garcia-Rivero A, Sanchez-Verde L, et al. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma. Histopathology. 2002;41:216-229.
6. Achten R, Verhoef G, Vanuytsel L, et al. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell subtype showing characteristic morphologic and immunophenotypic features. Histopathology. 2002;40:31-45.
7. Segal GH, Jorgensen T, Masih AS, et al. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low-grade B-cell lymphoproliferative disorders of nonfollicular center cell type. Hum Pathol. 1994;25:1269-1275.
8. Segal GH, Jorgensen T, Scott M, et al. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: II. Follicular lymphomas. Hum Pathol. 1994;25:1276-1282.
9. De Jong D, Van Gorp J, Sie-Go D, et al. T-cell-rich B-cell non-Hodgkin's lymphoma: a progressed form of follicle center cell lymphoma and lymphocyte predominant Hodgkin's disease. Histopathology. 1996;28: 15-24.
10. Delabie J, Vandenberghe E, Kennes C, et al. Histiocyte-rich B-cell lymphoma: a distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's diseases, paragranuloma subtype. Am J Surg Pathol. 1992;16:37-48.
11. Chittal SM, Brousset P, Voigt JJ, et al. B-cell lymphoma rich in T-cells and simulating Hodgkin's disease. Histopathology. 1991;19:211-220.
12. McBride JA, Rodriguez J, Luthra R, et al. T-cell rich B large-cell lymphoma simulating lymphocyte rich Hodgkin's disease. Am J Surg Pathol. 1996;20:193-201.
13. Felgar RE, Steward KR, Cousar JB, et al. T-cell-rich large-B-cell lymphomas contain nonactivated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large B-cell lymphomas. Am J Pathol. 1998;153:1707-1715.
14. Dogan A, Burke JS, Goteri G, et al. Micronodular T-cell/histiocyte-rich large B cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis. Am J Surg Pathol. 2003;27:903-911.
15. Dogan A, Bagdi E, Munson P, et al. CD10 and Bcl-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol. 2000;24:846-852.
16. Flenghi L, Ye BH, Fizzotti M, et al. A specific monoclonal antibody (PG-B6) detects expression of the Bcl-6 protein in germinal center B cells. Am J Pathol. 1995;147:405-411.
17. Cattoretti G, Chang CC, Cechova K, et al. Bcl-6 protein is expressed in germinal center-B cells. Blood. 1995;86:45-53.
18. Onizuka T, Moriyama M, Yamochi T, et al. Bcl-6 gene product, a 92- to 98-Kd nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood. 1995;86:28-37.
19. Falini B, Bigerna B, Pasqualucci L, et al. Distinctive expression pattern of the Bcl-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood. 1996;87:465-471.
20. Offit K, Lo Coco F, Louie DC, et al. Rearrangement of the Bcl-6 gene as a prognostic marker in diffuse large cell lymphoma. N Engl J Med. 1994; 331:74-80.
21. Lo CF, Ye BH, Lista F, et al. Rearrangements of the Bcl-6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood. 1994;83:1757-1759.
22. Kramer MH, Hermans J, Wijburg E, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood. 1998;92:3152-3162.
23. Camacho FI, Mollejo M, Mateo MS, et al. Progression to large B-cell lymphoma in splenic marginal zonal lymphoma: a description of a series of 12 cases. Am J Surg Pathol. 2001;25:1268-1276.